Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 174
Newswise: Tarloxotinib “very promising” against NRG1-fusion cancers
  • Embargo expired:
    1-Apr-2019 2:00 PM EDT

Tarloxotinib “very promising” against NRG1-fusion cancers

University of Colorado Cancer Center

University of Colorado Cancer Center study presented at the American Association for Cancer Research (AACR) Annual Meeting 2019 shows that the clinical-stage drug, tarloxotinib, is active against NRG1-fusion cancers, in addition to the HER2/EGFR cancers for which the drug was originally designed.

Channels: Medical Meetings, Cancer, Respiratory Diseases and Disorders,

Released:
28-Mar-2019 11:05 AM EDT
Open in New Tab
Comment
Newswise: The sneaky way estrogen drives brain metastasis in non-estrogen-dependent breast cancers

The sneaky way estrogen drives brain metastasis in non-estrogen-dependent breast cancers

University of Colorado Cancer Center

University of Colorado Cancer Center study published in the journal Oncogene shows that while estrogen doesn’t directly affect triple-negative breast cancer cells, it can affect surrounding brain cells in ways that promote cancer cell migration and invasiveness.

Channels: All Journal News, Cancer, Cell Biology, Women's Health, Grant Funded News,

Released:
7-Mar-2019 2:05 PM EST
Open in New Tab
Comment
Research Results
Newswise: Leaders meet in Colorado to set research agenda for early-onset colorectal cancer

Leaders meet in Colorado to set research agenda for early-onset colorectal cancer

University of Colorado Cancer Center

While overall rates of colorectal cancer are down, the rate of young people getting the disease is up 22 percent over two decades. International leaders meet in Colorado to set the research agenda to figure out why.

Channels: Cancer, Digestive Disorders, Local - Colorado, Medical Meetings,

Released:
1-Feb-2019 12:05 PM EST
Open in New Tab
Comment
Research Results
Newswise: Cancer Stem Cells Use “Normal” Genes in Abnormal Ways

Cancer Stem Cells Use “Normal” Genes in Abnormal Ways

University of Colorado Cancer Center

University of Colorado Cancer Center study shows that "normal" gene CDK1 interacts with "abnormal" gene Sox2 to keep cancer stem cells "stemmy."

Channels: All Journal News, Cancer, Cell Biology, Stem Cells, Local - Colorado,

Released:
12-Oct-2018 8:05 AM EDT
Open in New Tab
Comment
Research Results
Newswise: Cancer Hijacks the Microbiome to Glut Itself on Glucose

Cancer Hijacks the Microbiome to Glut Itself on Glucose

University of Colorado Cancer Center

A University of Colorado Cancer Center study published today in the journal Cancer Cell shows that leukemia undercuts the ability of normal cells to consume glucose, thus leaving more glucose available to feed its own growth.

Channels: All Journal News, Cancer, Cell Biology, Diabetes, Local - Colorado, Microbiome,

Released:
28-Sep-2018 11:05 AM EDT
Open in New Tab
Comment
Research Results

Showing results

110 of 174

Chat now!
0.7204